The World Health Organization WHO has given authorization to the Chinese-made “Sinovac” vaccine for emergency use, “giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy, and manufacturing,” the WHO stated.
The Sinovac vaccine is recommended for people over the age of 18 and requires 2 doses at a 2-4 week interval.
Sinovac is the seventh vaccine that WHO has listed for emergency use, along with Pfizer / BioNTech, AstraZeneca, Serum, Janssen and Moderna, and Sinopharm vaccines.
Georgia received 100,00o doses of Sinovac on April 29.
By Ketevan Skhirtladze